Skip to main content
OpenTrials

Clinical trial condition

SARS-CoV 2

Explore clinical trials studying SARS-CoV 2. Study availability and eligibility vary by location and protocol.

77 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

SARS-CoV 2 trial results

Completed

Convalescent Plasma to Limit SARS-CoV-2 Associated Complications

NCT04373460

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Center for American Indian Health - Chinle Office Chinle, Arizona, United States
  • Mayo Clinic, Phoenix Phoenix, Arizona, United States
  • University of Arizona, Phoenix Tucson, Arizona, United States
View all 29 locations
View Trial Details
Completed

The Safety of Molnupiravir (EIDD-2801) and Its Effect on Viral Shedding of SARS-CoV-2 (END-COVID)

NCT04405739

Conditions
SARS-CoV 2
Locations
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
  • Cook County Hospital Chicago, Illinois, United States
  • Advocate Christ Medical Center Oak Lawn, Illinois, United States
  • Advocate Lutheran General Hospital Park Ridge, Illinois, United States
View Trial Details
Completed

Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19

NCT04390139

Conditions
Adult Respiratory Distress Syndrome, COVID-19, Coronaviridae Infections, +13 more
Locations
  • Hospital de Bellvitge L'Hospitalet de Llobregat, Barcelona, Spain
  • Mútua de Terrassa Terrassa, Barcelona, Spain
  • Hospital del Mar Barcelona, Spain
  • Hospital Vall d'Hebron Barcelona, Spain
View Trial Details
Completed

International SARS-CoV-2 (COVID-19) Infection Observational Study

NCT04385251

Conditions
COVID, COVID-19, Coronaviridae Infections, +17 more
Locations
  • Denver Public Health Denver, Colorado, United States
  • Hospital General de Agudos JM Ramos Mejia Servicio de Inmunocomprometidos Buenos Aires, Argentina
  • CHIP Department of Infectious Diseases Copenhagen, Denmark
  • University College London Medical School Centre for Sexual Health and HIV Research London, England, United Kingdom
View Trial Details

Related conditions